Board approves cBHT policy

Published December 11, 2020

The APC Board of Directors has approved the alliance’s official policy statement on compounded bio-identical hormone therapy.

Highlights of the statement:

  • APC opposes any additional regulation of cBHT.
  • APC supports all compounded hormone therapy, with no preference for particular dosage forms.
  • APC opposes restrictions that would limit hormone compounding to pharmacies that adhere to cGMP.

Click here to read the full statement, and visit A4PC.org/cbht for all our latest information on the fight to protect cBHT.